BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20922432)

  • 1. Risperidone-induced bulbar palsy-like syndrome.
    Sico JJ; Patwa H
    Dysphagia; 2011 Sep; 26(3):340-3. PubMed ID: 20922432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphagia associated with risperidone therapy.
    Stewart JT
    Dysphagia; 2003; 18(4):274-5. PubMed ID: 14571332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dysphagia or dysphagias during neuroleptic medication?].
    Chaumartin N; Monville M; Lachaux B
    Encephale; 2012 Sep; 38(4):351-5. PubMed ID: 22980477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
    Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
    Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
    Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
    J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone and dysphagia.
    Varghese ST; Balhara YP; George SA; Sagar R
    J Postgrad Med; 2006; 52(4):327-8. PubMed ID: 17102565
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
    Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
    Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone-induced hyperprolactinemia in adolescents: A case series.
    Madhusoodanan S; Moise D
    J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risperidone-induced symptomatic hyperprolactinemia in youth with schizophrenia: efficacy and tolerability of cabergoline treatment].
    Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Mazza M; Di Michele V; Roncone R; Casacchia M
    Clin Ter; 2007; 158(2):121-6. PubMed ID: 17566512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
    Cavallaro R; Cocchi F; Angelone SM; Lattuada E; Smeraldi E
    J Clin Psychiatry; 2004 Feb; 65(2):187-90. PubMed ID: 15003071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia.
    Lin CH; Hsu CW; Tsao TY; Chou J
    Diagn Pathol; 2012 Jan; 7():2. PubMed ID: 22221904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
    Iuppa CA; Diefenderfer LA
    Ann Pharmacother; 2013 Sep; 47(9):1223-8. PubMed ID: 24259741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone-associated ejaculatory and urinary dysfunction in male adolescents.
    Holtmann M; Gerstner S; Schmidt MH
    J Child Adolesc Psychopharmacol; 2003; 13(1):107-9. PubMed ID: 12804132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone side effects.
    Conley RR
    J Clin Psychiatry; 2000; 61 Suppl 8():20-3; discussion 24-5. PubMed ID: 10811239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-induced hyperprolactinemia in an elderly woman.
    Bai YM; Ciu HJ; Guo ZZ
    Am J Psychiatry; 2002 Dec; 159(12):2112. PubMed ID: 12450970
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperprolactinemia with low dose of risperidone in a young female.
    Boothby A; Shad MU
    Asian J Psychiatr; 2017 Jun; 27():69-70. PubMed ID: 28558899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.